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ABSTRACT OF THE THESIS
THE EFFECTS OF DYNAMIC CULTURING ENVIRONMENTS ON CELL
POPULATIONS RELEVANT TO HEART VALVE TISSUE ENGINEERING
by
Catalina Martinez
Florida International University, 2011
Miami, Florida
Professor Sharan Ramaswamy, Major Professor
The design of a tissue engineered pulmonary valve (TEPV) involves cells
source(s), scaffold, in vitro conditioning system and the functional stability
of the TEPV in vivo. Vascular cells (pulmonary artery smooth muscle
(SMCs) and endothelial cells (ECs)) and periodontal ligament derived
stem cells (PDLSCs) are relevant sources for the designing of TEPVs. In
this study, labeling of these cell populations with super paramagnetic iron
oxide microparticles along with concomitant usage of transfection agents
was

followed

by

visualization

using

magnetic

resonance,

while

Intracellular iron oxide was confirmed by prussian blue staining and
fluorescence microscopy. Also, the potential of PDLSC as a feasible
source for TEPVs was investigated, expressing differentiative capacity to
both SMC and EC phenotypes by a combination of biochemical and
mechanical stimulation. Flow conditioning in a u-shaped bioreactor
augmented collagen production in SMC-EC (99.5% for n=3) and PDLSC
(93.3% for n=3) seeded scaffolds after a 3-week culturing period (P<0.05).
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1. INTRODUCTION
There are over 25,000 infants born with congenital heart anomalies in the
US alone (www.congenitalheartdefects.com), which usually demand either
replacement of the pulmonary valve (PV) and/or reconstruction of the right
ventricular outflow tract (RVOT). Available PV replacements in the market are:
mechanical, xenograft fixed-tissue, and homograft valves. Prosthetic heart valves
are implanted in approximately 275,000 patients yearly (1). However, current
prosthetic heart valves have several limitations. Mechanical valves are prone to
thrombosis; therefore life-long anticoagulant therapy is required (2). Xenograft
fixed-tissue, commonly referred to as bioprosthetic heart valves do not require
anticoagulants, but they have limited durability and are prone to calcification (3).
Homograft valves are limited in availability and often experience immune
rejection (4). Overall, none of these valve replacement strategies offer potential
for growth, and are hence particularly limited for pediatric patients, as they will
require multiple operations during their development. (1,5-7).
2. LITERATURE SEARCH
2.1 Heart Valve Disease (HVD) – Heart Valve disease (HVD) results from
the malfunctioning of one or more heart valves and is affected by factors such as
immune reaction, trauma, inheritance and environmental factors (diet, smoking,
etc.). The main job of heart valves is to open and close in a synchronized manner
allowing blood to flow in one direction and preventing back flow. A significant
amount of HVD is characterized by valve stenosis, causing the valve to become
narrow, therefore affecting hemodynamics by decreasing the cross sectional
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area for blood to flow. Similarly, improper valve closure causes regurgitation,
creating a backflow of blood into the heart. In this study, we are specifically
concerned with the pulmonary valve (PV), which lies between the right ventricle
and the pulmonary artery and has three cusps responsible for blood flow from the
heart to the lungs, as well as the exchange of oxygen and carbon dioxide.
Malfunction of a PV demands a replacement by currently available designs.
2.2 PV Replacements – The actual PV replacements available are
mechanical, bioprosthetic or homograft valves. Mechanical heart valves (MHVs)
are generally built from of titanium or pyrolytic carbon; their first designs include
the caged ball, tilting disk and bileaflet versions (2). Bioprostheric heart valves
(BHVs) are native valves usually derived from bovine or porcine sources, which
undergo a fixative chemical process before implantation in the human body (6,7).
All of these replacements are beneficial for the patient; yet they have serious
limitations. For example, MHVs are durable, but are thrombogenic, require lifelong anticoagulants, and therefore are more prone to infection (2). BHVs do not
require anticoagulants, but do not last as long as MHVs as they undergo
calcification on their leaflets (3). Homograft valves on the other hand, contain
some viable cells which would permit some tissue remodeling activity; however
as they are allografts, the often experience immunological rejection.
2.3 Tissue Engineered Heart Valves (TEHV) – Tissue engineering
applies principles of engineering and life sciences toward the development of
biological substitutes. This approach utilizes a bioabsorbable scaffolding material,
seeded with cells and grown in vitro, to ultimately produce functional living tissue
2

which can be implanted in the body (8). The extracellular matrix (ECM) formed by
the autologous cells provides the basic framework for the tissue and it is also
responsible for its mechanical and structural properties. Cells organize, grow,
proliferate and produce native ECM on the scaffold’s temporary matrix. In theory,
due to their ability to permit somatic growth, the creation of a tissue-engineered
structure from autologous cells can potentially offer several advantages over
currently available treatment options (1, 4, 8). Additionally, tissue engineered
pulmonary heart valves (TEPVs) would have fewer supply limitations in
comparison with homografts. The Mayer group (9) found promising results,
creating PV leaflets and sections of the main pulmonary artery. These structures
were found to be non-thrombogenic and promote tissue remodeling. However,
they had limited durability in the order of months (9). Sutherland et al.
constructed TEHVs by seeding bone marrow derived stem cells (BMSC) onto
nonwoven scaffolds that functioned in the pulmonary outflow tract of sheep for 8
months (8). While the results from these studies are clearly encouraging, the
current critical step for TEHV research is to identify a clinically viable autologous
cell source, a scaffold with the suitable mechanical and biodegradable properties,
an optimized in vitro conditioning system, and a way to track the functional
stability of the tissue engineering implant in vivo in order to successfully move
forward from in vitro conditioning into in vivo studies, and subsequently to clinical
trials (10).
2.4 Cell Sources for Tissue Engineered Pulmonary Valves – Three
relevant cell sources pertinent in tissue engineered hear valve efforts include

3

human vascular cells (native pulmonary artery smooth muscle

(SMCs) and

endothelial cells (ECs)) and stem cell sources. Vascular cells (SMCs and ECs)
have shown to promote heart valve tissue formation (1, 9, 11). Therefore, these
vascular cells need to be assessed in order to track tissue remodeling in vivo.
Studies using bone marrow derived stem cells (BMSCs) which are readily
accessible, have shown that after a TEPV has been implanted, the BMSCs
exhibit some pluripotency for potential vascularization of bioengineered tissues
(8). Evidence of smooth muscle cell phenotype has been obtained by Sutherland
et al. (8) by expressing vimentin, and alpha-smooth muscle actin (alpha-SMA)
markers in his studies. However they could not detect evidence of endothelial cell
phenotype.
Human periodontal ligament derived stem cells (PDLSCs) on the other
hand, are a readily available source of pluripotent stem cells that may potentially
support the valve phenotype. They are derived from the cranial neural crest and
recent studies by Huang et al. (12) have shown that PDLSCs are a population of
multipotent stem cells that can be differentiated into neural and mesenchymal
lineages. Sub-populations of PDLSCs contain 4 embryonic stem cell markers
(Oct4, Nanog, Sox2, Klf4) and exhibit the potential to differentiate to neurogenic,
cardiomyogenic, osteogenic and chondrogenic cell lineages (12). Therefore,
PDLSCs have the potential to promote concomitant differentiation into the EC
and SMC phenotypes (12-14).
2.5 Scaffold Material for Tissue Engineered Pulmonary Valves – The
scaffold material serves as a support structure capable of retaining cells and
4

engineered tissue formation. Scaffold materials must allow cell attachment and
migration, enable diffusion of cell nutrient and expressed products, as well as
possess mechanical and biological properties to provide structural support.
TEPVs are usually constructed by seeding cells onto porous synthetic of natural
scaffolds (5). Natural scaffolds, from decellularized valve tissue already have
proper anatomical structure, intrinsic bioactivity and desired mechanical
properties (5). However, their innate variability, limited supply, and potential
immunogenic reaction are obstacles in the field.
On the other hand, synthetic scaffolds offer the added benefit of design
flexibility, in which their material and structural properties, as well as anatomical
shape can be tailored to meet the functional necessities (15,16). Polyesters such
as polyglycolic acid (PGA) and poly-l-latic acid (PLLA) are the most widely used
scaffold materials in the field of TEPVs. These materials mixed together in a
50:50 blend create an immunogenic scaffold capable of degrading by hydrolysis
into naturally occurring metabolites (15,16). This scaffold has an approximate
fiber diameter of 0.012-0.015mm and a density of 61.75 mg/ml. Its benefits
include a high porosity factor (>97%) allowing for a high cell seeding density.
The PGA/PLLA scaffold has already been successful demonstrating its ability to
rapidly grow cells and form an organized 3D tissue structure (1,5).
2.6 In Vitro Conditioning Systems – Mechanical stimulation of
engineered tissue growth in vitro can be achieved with a bioreactor, which has
shown to improve the physical integrity of engineered heart valves prior to
implantation (9,16,17). The mechanical environment would potentially include a
5

physiological flow and pressure for conditioning the developing valve tissue
construct in a sterile setting prior to in vivo implantation (17-19). Different
bioreactors have been designed by researchers to promote tissue formation and
valve phenotype (5,9,16-19).

Hoerstrup et al (17) developed an in vitro cell

culture system that provided the developing valve constructs with physiological
pressure and flow to develop adequate strength of the constructs prior to
implantation.

In a similar manner, Sticker et al (18) conducted a study to

compare tissue samples exposed to stretch versus normal conditions showing
there is higher tissue production on samples treated mechanically, i.e exposed to
cyclic flexure. Engelmayr et al (5) showed that laminar flow combined with cyclic
flexure in a flow-stretch-flex (FSF) bioreactor allowed for larger tissue formation
when compared to laminar flow without cyclic flexure when seeding BMSCs in a
non-woven scaffold material (PGA/PLLA). However, Engelmayr this study did not
use physiological levels, as the shear stresses were very low. The effects of fluid
shear stresses on engineered tissue growth levels (i.e. collagen) can be
evaluated in terms of bulk protein levels, differentiation potential, mechanical
properties, gene expression and cell signaling events.
The device utilized in our study, is an u-shaped bioreactor capable of
replicating physiological hemodynamic conditions during in vitro tissue
development, while keeping laminar conditions as shown by precise steady state
states. This is a key advantage over other bioreactor designs incapable of
generating physiologically relevant stresses, which have been widely recognized
as an essential aspect of engineered heart valve tissue formation (5,16).
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2.7 Noninvasive Visualization of Functional TEPV’s – A cell-tracking
agent is required to be safe to use, i.e., does not alter cell activity, and permits
retention within the cell for a reasonable period to allow for visualization over
longitudinal time points (20). One approach would be to label the cells with super
paramagnetic iron oxide (SPIO) microparticles and visualize the resulting
artifacts as regions of signal voids characterized using magnetic resonance
imaging (MRI). Other cell tracking methods include labeling with green
fluorescent protein (GFP). However, this method is harmful for the tissue, as it
may interfere with the protein synthesis of the cells and does not provide
sufficient resolution beyond that of subcutaneous tissue, which is needed for the
heart valve application (21). Another cell tracking method involves gadolinium
compounds, which create contrast through T1 images, however the main
disadvantage of this contrast agent lies on its low sensitivity (22). On the other
hand, SPIO microparticles have already been demonstrated to work for MRI
investigations without harming the cell (23-26). For example, Terrovitis et al. (24)
showed that labeling BMSCs with ferumoxides was not toxic to the cells, and the
cells could further be visualized in collagen gels/scaffolds. Ko et al. (27) showed
that cellular MRI methodologies could further be used to visualize an implanted
scaffold and the cellular behavior around the scaffold in the mouse model.
MRI has been reported to be useful in monitoring TEPV growth and
function in vivo (20). MRI allows cell detection utilizing SPIO microparticles as
the contrast agent by accelerated T2* decay, which will present as hypointense
regions caused by the intracellular iron oxide particles (10). This visualization is
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necessary from the beginning of the in vitro culturing period of the engineered
construct and could in theory be progressively tracked, even after implantation (8,
28-30).
To understand a process where there are many unknowns, such as the
cell migration that will occur on the scaffold region, we propose to use SPIO and
cellular MRI. These include the migration of cells within and outside of a scaffold
region, as well as the potential migration of native cells into the scaffold from
regions proximal to the site of the implant. The ability to observe the type of cells
that would adhere/migrate longitudinally and preferentially in/out of the scaffold
material is a key aspect in predicting the quality and quantity of tissue that would
form. On the other hand, efforts to label and track PDLSCs, a potential cell
source in heart valve tissue engineering has to date not been performed.
3. OBJECTIVES
Our objectives were to conduct an in-depth study of the longitudinal position and
migration patterns of cells during the engineered heart valve tissue development
process under static and dynamic environments. This would be achieved through
SPIO cell labeling and subsequent tracking studies by MRI. In addition, we
wanted to investigate the potential of PDLSCs as a single, feasible source for
heart valve tissue engineering. These hypothesis are addressed by the following
specific aims:
3.1 Specific Aim 1: Acquire longitudinal MRI images of SPIO-labeled
cell populations in engineered valve tissue in cell culture with maximum
possible cell contrast without compromising cell viability, proliferation and
8

differentiative capacity – Specifically, we wish to augment iron oxide uptake in
human vascular cells (native pulmonary artery smooth muscle

(SMCs),

endothelial cells (ECs)) and label human periodontal ligament derived stem cells
(PDLSCs) from currently used protocols without compromising cellular viability
and without affecting cell phenotypes.
3.2 Specific Aim 2: Differentiate PDLSC into concomitant EC and
SMC through use of a growth factor cocktail, mechanical stimulation or
both – PDLSCs would be differentiated into ECs and SMCs in cell culture with
growth factors, and/or would be mechanically stimulated under steady flow using
shear stress at 1 dyne/cm2 to promote further differentiation that is supportive of
the heart valve phenotype.
3.3 Specific Aim 3: Perform biological studies of the SPIO-labeled
cells in 3D static or dynamic polymer seeded scaffolds determine
extracellular matrix (ECM) production and changes in cell phenotype – Cellseeded polymers would be housed in a bioreactor and exposed to fluid induced
shear stress conditioning. Vascular cell migratory activity under dynamic states
would be compared to static controls by means of SPIO as the contrast agent.
4. MATERIALS AND METHODS
4.1 Aim 1 Methodologies
Cell Labeling: Various concentrations of Bangs particles (Bangs
laboratories, Fishers, IN), which are co-labeled with a fluorescent red tag
(excitation=660nm, emission =690nm) were used to label the vascular cells
9

(Genlantis, Fisher Scientific, IN) at two different incubation times (24 hours and
48 hours), while the PDLSCs (University of Miami, Tissue Engineering
Laboratory, Miami, FL) were labeled at an incubation time period of 24 hours.
After proliferating all cell lineages, roughly, 3 million cells and were re-plated
equally into 15 chamber slides (Fisher Scientific, PA). Vascular cells (n=5) were
labeled for a 24 hour period with three different concentrations of SPIO
microparticles (0.23g of Fe per ml of solution: 50, 100 and 200 μg/ml).
Concomitantly, during the same 24 hour period, cells were exposed to 4.5μg/ml
of a transfection agent (Protamine Sulfate, Sigma, MO). A second group of the
vascular cells were labeled with ferumoxides in the same manner except that the
incubation time was doubled, i.e., 48 hours. On the contrary, the PDLSCs were
labeled following the protocol used by Suzuki et al. (31) for embryonic stem cells.
The PDLSCs (n=5) were labeled with SPIO microparticles at a concentration of
200 μg/ml for 24 hours. During this 24-hour period, the PDLSC’s were also
exposed to a 12μg/ml of the transfection agent (Protamine Sulfate, Sigma, MO).
MR Imaging of Cells in Culture: For vascular cells (SMC and EC), MRI
datasets were collected on a 4.7-Tesla (200MHz) 40-cm bore magnet with a
Bruker Avance™ (Bruker Inc., Rheinstetten, Germany) console using an actively
shielded gradient set. A linear birdcage radio frequency (RF) coil with a diameter
of 35mm was used for imaging the samples in order to increase sensitivity of
signal detection. A 2D gradient echo fast imaging (GEFI) pulse sequence with
180mm resolution and 10ms time of echo (TE) was employed to visualize the
labeled vascular cells in the chamber slide. On the other hand, for PDLSC, MRI
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datasets were collected on a 3.0-Tesla (123MHz) 60-cm bore magnet with a
Magnetom Trio, (Tim, Simens) console using an actively shielded gradient set. A
transmit/receive 15 channel knee coil that provides high resolution.

A 3D

gradient echo pulse sequence with 60mm resolution and 11.2ms TE and 100ms
relaxation time (TR) was employed to visualize the labeled PDSLCs in the
chamber slide.
Proliferation and Viability: SPIO-labeled and unlabeled cells (EC, SMC
and PDLSC) were cultured for 1 week to assess proliferation and viability. EC’s
were cultured using Genlantis medium (Genlantis, San Diego, CA) while SMCs
and PDLSC’s were grown in-vitro using Dulbecco’s Modified Eagle’s Medium
(DMEM, Lonza, Basel, Switzerland) with 4.5 g/l glucose and l-glutamine
(Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS,
ATCC, Manasas, VA), and 1% penicillin/streptomycin (Invitrogen, Carlasbad, CA).
At both the beginning and end of 1 week, live cells were manually counted using
a hemocytometer. Dead cells were excluded by addition of Trypan Blue dye
(Sigma Aldrich, St. Louis, MO) prior to the counting process.
Iron Oxide Detection: After culturing SPIO-labeled and unlabeled cells
(SMC, EC and PDLSC) for a week, they were rinsed with 0.01M Phosphate
Buffered Saline (PBS) and detached from the T-75cm2 flask (Fisher Scientific,
PA) by 0.25% Trypsin-EDTA (ATCC, Manasas, VA). Cell pellets were collected
in a 15 ml conical tube (Fisher Scientific, PA) and transferred to chamber slides
(n=6 per cell type). After the cells attached overnight, they were fixed with 10%
formalin for further detection of iron oxide. Prussian Blue Stain: Slides (n=3 per
11

cell type) were then incubated in a 1:1 working solution of 2% Potassium
Ferrocyanide and 2% Hydrochloride acid for 20 min at 55OC, washed in tap water
followed by a counterstain of nuclear fast red for 5 min. The slides were then
dehydrated through alcohol, and cleared in xylene. After mounting the slides with
Permount (Fisher Scientific, PA) they were examined under an upright
microscope for presence of iron particles inside the cells. Fluorescent red tag in
Bangs Particles: Slides (n=3 per cell type) were counterstained for filamentousactin (F-actin, Invitrogen, Carlsbad, CA) using Alexa Fluor 488 conjugated
phallotoxin at 5U/mL for 20 min at 26OC, and washed in PBS. The slides were
then mounted and stained for DAPI with Vectashield Mounting Media (Invitrogen,
Carlsbad, CA)) and examined under an inverted fluorescent microscope for
presence of the red tag contained in the magnetic core of the Bangs particles
(660 excitation, 690 emission).
RNA Isolation and Reverse Transcription: The cells (SMC, EC and
PDLSC) were rinsed with PBS and detached from the T-75cm2 flask (Fisher
Scientific, PA) by 0.25% Trypsin-EDTA (ATCC, Manasas, VA). Cell pellets were
collected in a 15 ml conical tube (Fisher Scientific, PA). The pellet was
transferred to a 1.5 ml RNAase free tube to perform the RNA isolation procedure.
Total mRNA was purified with SV Total RNA Isolation System (Promega,
Madison, WI). 1µg of total mRNA was used for reverse transcription reaction with
GoScript™ Reverse Transcription System (Promega, Madison, WI). The cDNA
was synthesized using oligo (dT)15 primer, according to the manufacturer’s
instructions.
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qRT-PCR for SMC, EC and PDLSC Marker Genes: Quantitative RTPCR was performed using GoTaq® qPCR Master Mix (Promega, Madison, WI).
Signals were detected with a Step One Real-Time PCR System (Applied
Biosystems, Carlsbad, CA). The PCR tube contains 2 primers and SYBR® green
I dye reagent along with the cDNA, a product of reverse transcription mentioned
above. The primers were designed to amplify the target sequence. The PCR
primer sequences for SMC, EC and PDLSC are listed in Table 1. The sample
tube was held at 950C, 2 minutes before the cycle started to activate the Taq
polymerase. The cycling parameters were 950C, 5 seconds; 600C, 45 seconds;
950C, 15 seconds.
Table 1: qRT-PCR Primer Sequences
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4.2 Aim 2 Methodologies
Cell Differentiation: After PDLSCs reached 100% confluency, they were
separated into 4 groups during a week period at a cell density of 1*106 cells/cm2.
Group [1] – Negative control: This group contained PDLSCs cultured in its basal
media. Group [2] – Differentiating Media: This group contained PDLSCs exposed
to a special media believed to induce SMCs and ECs differentiation. Group [3] –
BioFlux: This group of PDLSCs was subjected to a physiologically relevant shear
flow (1 dyne/cm2) while being cultured in the Bioflux200 system (Fluxion, San
Francisco, CA). Group [4] – Differentiating Media + BioFlux: This group combined
the special media and the physiological relevant shear flow (1 dyne/cm2) while
culturing the PDLSC inside the Bioflux200 system (Fluxion, San Francisco, CA).
As positive control, both human vascular EC and SMC were utilized. [1] Negative
control: This group contained PDLSCs cultured in its basal media. [2]
Differentiating Media: This group contained PDLSCs exposed to a special media
believed to induce SMCs and ECs differentiation. [3] BioFlux: This group of
PDLSCs was subjected to a physiologically relevant shear flow (1 dyne/cm2)
while being cultured in the Bioflux200 system (Fluxion, San Francisco, CA). [4]
Differentiating Media + BioFlux: This group combined the special media and the
physiological relevant shear flow (1 dyne/cm2) while culturing the PDLSCs inside
the Bioflux200 system (Fluxion, San Francisco, CA). As positive control, both
human vascular EC and SMC were utilized.
Differentiating Media: The cocktail mix utilized to culture cells in groups
[2] and [4] was hypothesized to induce differentiation of PDLSCs into EC and
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SMC concomitantly as a similar version of the mix has already been effective in
differentiating PDLSCs into cardiomyocytes (32). Therefore, since PDLSCs can
be differentiated into other cardiovascular cell lineages, such as cardiomyocytes,
it serves to argue that they have the potential to become vascular SMCs and/or
ECs (33,34). The cocktail mix we have utilized contains DMEM High glucose
(Invitrogen, Carlsbald, CA), 10% fetal bovine serum (ATCC, Manasas, VA), 1%
Penicillin/streptomycin (ATCC, Manasas, VA), as well as 10ng/mL of vascular
endothelial growth factor (VEGF, BD Science, USA), 25ng/mL of basic fibroblast
growth factor (bFGF, Invitrogen, Carlsbald, CA), 10ng/mL of Insulin-like Growth
Factor (IGF-1, Invitrogen, Carlsbald, CA), 10uM of 5-azacytidine (Sigma Aldrigh,
St. Louis, MO), 100nM Ascorbic Acid (Sigma Aldrich, St. Louis, MO), 10nM
Oxytocin (Sigma Aldrigh, St. Louis, MO),

10nM hydrogen peroxide (Sigma

Aldrich, St. Louis, MO). The cocktail mix was changed every two days during a
1-week period, with exception of the hydrogen peroxide, which was added daily.
BioFlux 200 System: This system enables the user to prepare 8 cell
assays in parallel, while controlling their temperature. Its interface connects an
electropneumatic pump to the well plates, which initiates the “controlled shear
flow”. BioFlux 200 can also be connected to an inverted regular or fluorescent
microscope; allowing the user to for example, perform immunohistochemical
findings while the cells are being stimulated. Therefore, this system is highly
conducive for assessing stem cell differentiation outcomes.
Cell Phenotype: After the 1-week period of culturing the cells under the
differentiating media, cells from the four separate groups were subjected to PCR
15

and immunohistochemistry in order to check for SMC and EC cell phenotypes.
RNA isolation, reverse transcription and qRT-PCR methods were performed in a
similar manner to that of the labeled cells as described earlier for the SPIOlabeling studies.
Immunohistochemistry:

Characterization

of

cell

phenotype

by

immunohistochemistry was performed. After the 1-week culture period, cells from
all groups were rinsed with PBS and detached from the T-75cm2 flasks (Fisher
Scientific, PA) by Trypsin-EDTA (ATCC, Manasas, VA). Cell pellets were
collected in a 15 ml conical tube (Fisher Scientific, PA) and transferred evenly to
chamber slides (n=6 per group) at a density of 200,000 per chamber slide. After
24 hours, the slides were fixed in 10% buffered formalin. Sections were then
washed in PBS-T 3 x 5min. The sections were incubated for 1 hour in Normal
Donkey Serum (1:10 in PBS-T). Next, the sections were incubated (Overnight,
4°C) with mouse alpha-smooth muscle actin (1:500, Sigma Aldrich, St. Louis,
MO) or rabbit von Willebrand Factor (vWF, 1:500, Invitrogen, Carlsbad, CA).
After washing in PBS, the sections were incubated in their secondary antibodies
for two hours Texas Red (1:800) anti-mouse IgG and Texas Red (1:400) antirabbit IgG, to identify anti-alpha-sma or anti-vWF respectively. The sections were
washed again with PBS 3x5min. Finally, the slides were mounted and stained for
DAPI with Vectashield Mounting Media (Invitrogen, Carlsbad, CA)) and examined
under an inverted fluorescent microscope.
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4.3 Aim 3 Methodologies
Cell Labeling: PDLSC’s were labeled with Bangs particles (Bangs
laboratories,

Fishers,

IN),

co-labeled

with

a

fluorescent

red

tag

(excitation=660nm, emission =690nm) at a concentration of 200ug/mL. SMCs
and ECs were labeled in a similar manner as previously described. However, the
Bangs particles utilized to label the SMCs were colabeled with a green tag
(excitation=480, emission=520) while the ECs were labeled with the Bang’s
particles colabeled with the red tag (excitation=660nm, emission =690nm) in
order to distinguish the cell type under a fluorescent microscopy.
Cell Seeding: A non-woven 50:50 blend of polyglycolic acid (PGA) and
poly-L-lactic acid (PLLA) scaffold (Biofelt, Concordia Fiber, RI) was utilized for
cell seeding. This scaffold has an approximate fiber diameter of 0.012-0.015mm
and its density is 61.75 mg/ml. Its benefits include its high porosity factor (>97%).
The PGA/PLLA scaffold has already been successful demonstrating its ability to
rapidly grow cells and form an organized 3D tissue structure (1,5). Rectangular
scaffold samples (n=12) of dimensions (17mm X 6mm X 1mm) were subjected to
Ethylene Oxide gas sterilization (AN 306, Anprolene, Andersen Products
Inc., Haw River, NC) for 12 hours. After the sterilization period, each sample was
placed in a hybridization tube and seeded with previously SPIO labeled and
unlabeled SMC (~87%) –EC (~13%) at a density of 2x106 million cells per cm2.
The hybridization tubes (n=2) were then placed on a rotisserie (Fisher Scientific,
PA) and rotated at 8rpm inside a standard cell culture incubator operating at
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37OC and 5% CO2 for one day+ 7days (static culture). The SPIO-labeled and
unlabeled PDLSC-plated scaffolds were seeded in the PGA/PLLA scaffold in a
similar manner.
Monitoring tissue development process: The mechanical conditioning
for the seeded scaffolds was developed in a u-shaped bioreactor shown on
Figure 1. This bioreactor is capable of replicating physiological hemodynamic

Figure 1: The u-shaped bioreactor for in vitro mechanical conditioning.

conditions during in-vitro tissue development, which has been widely recognized
to be an essential aspect of engineered heart valve tissue formation (5,16). Poststatic culturing of the scaffolds (n=12) during a total of 8 days in the rotisserie,
they were separated into two groups: static and flow. Scaffolds (n=6) were then
then cultured also for a two week period in dynamic conditions, housed in the ushaped bioreactor being exposed to a physiologically relevant continuous flow
rate (750 mL/min) which develops a shear stress of a 5-6 dynes/cm2 (18). The
tissue formation studies were based on the SMC-EC-seeded-scaffolds, as well
as the PDLSC seeded scaffolds.
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MRI of PDLSC-seeded Scaffold Inside Bioreactor: MRI datasets were
collected on a 3.0-Tesla (123MHz) 60-cm bore magnet with a Magnetom Trio,
(Tim, Simens) console using an actively shielded gradient set. A transmit/receive
15 channel knee coil that provides high resolution. A 3D gradient echo pulse
sequence with 60mm resolution and 11.2ms TE and 100ms relaxation time (TR)
was employed to visualize the labeled PDSLC-seeded scaffold inside the
bioreactor.
Histology: SPIO-labeled PDLSC-seeded scaffolds were fixed and
embedded with paraffin at different time points for the samples exposed to flow
or static conditions. While the samples cultured under static conditions were fixed
and embedded in paraffin at: 1-week post static culture, 2-weeks post static
culture and 3-weeks post static culture. Samples (n=2 at each time point/group)
were washed in PBS, and fixed in 10% formalin, then embedded in paraffin and
sectioned at 10um. Sections were stained with hematoxylin and eosin for overall
morphology.
Fluorescence Validation: In order to see the migratory activity of PDLSC
in the PGA/PLLA copolymer; and to validate the presence of iron through the
fluorescent tag of the Bang’s particles, sections were mounted and stained for
DAPI with Vectashield Mounting Media (Invitrogen, Carlsbad, CA)) and examined
under an inverted fluorescent microscope.
DNA Quantification: DNA was quantified after the 3 week by a technique
adapted from Ramaswamy et al. (35). For each assay, thin samples (8x7X1 mm)
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were cut from PDLSC/SMC-EC seeded scaffolds (controls, and scaffolds
exposed to flow) along their long axis and weighed prior to extraction. Each
sample was then placed in a microcentrifuge tube and extracted in 1ml of 0.125
mg/ml papain solution for 10 hours in a 60OC water bath. The 0.125mg/ml
papain solution must made immediately prior to use by adding l-cysteine
dihydrochloride (Sigma Aldrich, St. Louis, MO) to a phosphate buffered EDTA
solution (PBE, Sigma Aldrich, St. Louis, MO) to a concentration of 10 mM, adding
papain (minimum 10 units/mg (P4762); Sigma) to a concentration of 0.125mg/ml.
The PBE solution was made beforehand by adding sodium phosphate dibasic
(Sigma) and Ethylenediaminetetraacetic acid (EDTA; Sigma Aldrich, St. Louis,
MO) to deionized water at concentrations of 100 and 10 mM, respectively. The
PBE solution needs to be balanced to pH 6.5 with 0.5 N hydrochloric acid (Sigma
Aldrich, St. Louis, MO) and sterile filtered using a vacuum filtration unit (0.2 mm
PES membrane; Nalgene Labware). The extracts were then assayed using the
PicoGreen dsDNA quantitation kit (Invitrogen, Carlsbad, CA) as per the
manufacturer’s instructions and using a Genesys 20 spectrophotometer (Thermo
Spectronic, Rochester, NY).
Extracellular

Matrix

Quantification:

Collagen

and

sulfated

glycosaminoglycans (S-GAG) were assayed following a similar technique used
by Ramaswamy et al. (35). For the collagen assay, thin samples (8x7X1 mm)
were cut from PDLSC/SMC-EC seeded scaffolds (controls, and scaffolds
exposed to flow) along their long axis and weighed prior to extraction. Total
collagen was extracted from samples using a solution of 0.5M acetic acid (Sigma
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Aldrich) and pepsin ((1 mg/ml), Sigma Aldrich, St. Louis, MO). Each sample was
the placed in a microcentrifuge tube and incubated in 1ml of extraction solution
on a rocker table ((Orbitron Rotator); Boekel Scientific, Feasterville, PA) at 4OC
for 16 hours. For the S-GAG assay, the same extract used for the DNA assay
was utilized. Subsequent to the extraction procedure, the collagen and S-GAG
extracts were assayed following the protocols of the manufacturer’s provided by
Sircol and Blyscan assay kits. (Biocolor Ltd. Newtownabbey, N. Ireland) using a
Genesys 20 spectrophotometer (Thermo Spectronic, Rochester, NY).
4.4 Statistical Analysis
Statistical analysis was performed utilizing the SPSS Software Version
16.0 for the independent t-test for all proliferation and viability tests (n=5), as well
as gene expression tests (n=3) from Aim 1. For Aim 2, four different groups of
cells were compared; in addition we used ANOVA through MATLAB 7.12 to be
able to compare the three groups pairwise (1 to 2, 1 to 3, 1 to 4, etc), so the
probability of an incorrect result would be: 1 - (0.95 x 0.95 x 0.95) = 14.3% in
order to prevent type I and type II errors. Finally, SPSS Software Version 16.0
was also utilized for performing statistical analysis for extracellular matrix and
DNA quantification results (n=3, replicates=5) from Aim 3.
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5. RESULTS AND DISCUSSION PART I: SPIO MICROPARTICLE
LABELING STUDIES FOR THREE DIFFERENT CELL POPULATIONS,
IMPLICATIONS FOR TISSUE ENGINEERED HEART VALVES

MR Imaging of Cells in Culture: We determined that vascular cells
exposed to a concentration of 200 μg/ml of SPIO microparticles and incubated
for a period 48 hours was optimum for detection by MRI (Figure 2). Similarly,
PDLSCs were successfully imaged when exposed to a SPIO concentration of
200 μg/ml and incubated for a period of 24 hours (Figure 2e) (36,37).

Figure 2: (A-B) A cMR image of the SMCs with a 200μg/mL concentration of the SPIO particles. (A)
Under 24 hours incubation time. (B) Under 48 hours incubation time. (C-D) A cMR image of the ECs
under a 24 hours incubation time. (C) With a 100μg/mL concentration of the SPIO particles. (D) With
a 200μg/mL concentration of the SPIO particles. (E) A cMR image of the PDLSCs with a 200μg/mL
concentration of the SPIO particles under 24 hours incubation time.

Proliferation and Viability: Figure 3 and Figure 4 below show the
proliferation and viability for the vascular cells (SMCs and ECs) unlabeled, and
labeled for the three SPIO concentrations previously described after a 48 hour
incubation time. Figure 5 and Figure 6 show the proliferation and viability for the
PDLSC unlabeled and labeled at 200ug/mL. No significant (N.S, p>0.05) values
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were found between proliferation and viability between labeled and unlabeled
cells (SMCs, ECs, and PDLSCs). Viability for SMCs unlabeled cells (UC) was
89±3.5%, while for labeled cells (LC) it was75±3%. ECs, viability of UC was
89.8±2.7%, and LC was 87±2%. As for PDLSC (UC) was 96±1.3%, while for
labeled cells (LC) it was 94±1%. Proliferation of all cell types was doubled
measured over one week, and values were not significantly different (p>0.05)
between LCs and UCs.

Figure 3: Proliferation of human vascular cells SMC (green) and EC (red) unlabeled, and SPIOlabeled at three different concentrations: 50, 100 and 200 ug/m in a 48 hour incubation time. The
values for both cell types at the different cell concentration did not have any significant differences
(N.S) based on the independent t-test (n=5).
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Figure 4: Viability of human vascular cells SMC (green) and EC (red) unlabeled, and SPIO-labeled at
three different concentrations: 50, 100 and 200 ug/m in a 48 hour incubation time. The values for
both cell types at the different cell concentration did not have any significant differences (N.S) based
on the independent t-test (n=5).

Figure 5: Proliferation for PDLSC’s unlabeled and SPIO-labeled at a concentration of 200 ug/ml.
There were no statistical differences in the values based on the independent t-test (n=5).
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Figure 6: Viability for PDLSCs unlabeled and SPIO-labeled at a concentration of 200 ug/ml. There
were no statistical differences in the values based on the independent t-test (n=5).

Iron Oxide Detection: The Prussian blue stain was positive for iron oxide
particles inside the cells for the three cell lineages (Figure 7). On the other hand,
positive red staining indirectly confirmed intracellular iron oxide uptake as shown
in Figure 8 , Figure 9 and Figure 10.
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Figure 7: Prussian Blue Stain taken at 100X. Scale bar=200μm. Blue dots represent the iron, while
the cytoplasm is shown in a light pink color. (A) SMCs, (B) ECs and (C) PDLSCs cell populations.

Figure 8: Immunofluorescence of SMCs taken at 100X, Scale bar=200μm (Left) and 200X, Scale
bar=100μm(Right). Both images were stained for F-actin (green), DAPI (blue) and the fluorescence
from the Bangs particles (red).
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Figure 9: Immunofluorescence of ECs taken at 100X, Scale bar=200μm (Left) and 400X, Scale
bar=100μm(Right). Both images were stained for F-actin (green), DAPI (blue) and the fluorescence
from the Bangs particles (red).

Figure 10: Immunofluorescence of PDLSCs taken at 100X, Scale bar=200μm (Left) and 200X, Scale
bar=50μm(Right). Both images were stained for F-actin (green), DAPI (blue) and the fluorescence
from the Bangs particles (red).

qRT-PCR for SMC, EC and PDLSC Marker Genes: The change in cycle
threshold (∆Ct) values were averaged and normalized with GAPDH using the
∆∆Ct method (38). Fold changes were calculated as 2-∆Ct and the gene
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expression ratio of each of the three types of cells (SMCs, ECs and PDLSCs)
unlabeled relative to labeled indicated as shown on Figure 11, Figure 12 and
Figure 13. Specifically, for SMCs GAPDH, B-1 integrin and Thy-1 were both
expressed with no significant differences in UC and LC. For ECs, GAPDH, Flk-1,
and VE-Cadherin were all expressed with no significant differences; while
PECAM-1 was greatly expressed in LC compared to UC, and Tie-1 was
expressed greatly in UC compared to LC. Lastly, for PDLSCs, GAPDH, Klf4, and
Nestin were all expressed with no significant differences in both UC and LC. Also,
Slug was expressed greatly in UC compared to LC.

Figure 11: Quantitative RT-PCR of SMC unlabeled (2) and labeled with SPIO microparticles (2). Each
column is normalized by GAPDH (endogenous gene). Values for all genes were not statistically
different (n=3).
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Figure 12: Quantitative RT-PCR of EC unlabeled (5) and labeled with SPIO microparticles (5). Each
column is normalized by GAPDH. Values for all genes were not statistically different with exception
of PECAM 1 and Tie 1 (P < 0.05) (n=3).
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N.S

N.S
N.S

P < 0.05

Figure 13: Quantitative RT-PCR of PDLSC unlabeled (5) and labeled with SPIO microparticles (5).
Each column is normalized by GAPDH. Values for all genes were not statistically different with
exception of Sox 2 and Slug (P < 0.05) (n=3).

Treatments for congenital heart valve disease clearly need advanced
procedures for examining the effectiveness of the treatment during in vivo
conditions. MRI can be utilized in cellular processes to longitudinally track the
fate of cells seeded on a specific scaffold. Noninvasive longitudinal monitoring by
means of MRI is increasingly being utilized on processes related to cell and
tissue engineering. These developments can drastically aid in the evaluation of
tissue-engineered

constructs

(39,40).

SPIO

nanoparticles

have

been

demonstrated to work in MRI investigations without harming the cell in any way
(24-28). Terrovitis et al. showed that labeling BMSC’s with ferumoxides was not
toxic to the cells, and they could even be further visualized in collagen
gels/scaffolds (26). In another study performed by Ko et al (29) cellular MRI
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methodologies were demonstrated to allow for visualization of an implanted
scaffold as well as the cellular behavior around the scaffold in a mouse model.
He utilized SPIO-labeled-hMSCs, which were then cultured in a scaffold: gelatin
sponge to support cell growth and proliferation (29). In a similar manner, MRI has
been reported to be useful in monitoring tissue engineering heart valve (TEPV)
growth and function in-vivo by Hill et al (22). As mentioned earlier, MRI allows
cell detection by accelerated T2* decay, which are represented as hypointense
regions caused by the intracellular iron oxide particles (41). This visualization is
necessary from the beginning of the in-vitro culturing period of the engineered
construct and could in theory be progressively tracked, even after implantation
(41). Harrington et al (42) utilized cellular MRI to track the fate of SPIO labeled
macrophages seeded onto functional tissue engineered vascular grafts (TEVGs)
through serial imaging. In their study, seeded cells were rapidly lost from
implanted scaffolds instead of progressing into cells in the neovessel as
hypothesized by their group. However, their findings were a successful
application of noninvasive MRI for a serial study of cellular level processes in
tissue engineering (42).
In this study, the three cell lineages (SMCs, ECs and PDLSCs) proliferate
and were viable after being labeled with SPIO microparticles at 200 μg/mL They
were successfully visualized using T2* contrast by MRI 1 week post-labeling.
MRI slices were co validated by Prussian blue staining and fluorescence
microscopy confirmed the presence of the ferumoxide particles as evidenced by
the detection of the co-labeled red tag of the Bang’s particles intracellularly. The
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migratory activity of the cells could also be tracked longitudinally during their
developmental process, which would permit us to understand their in vivo
hemodynamic environment in future work.
6. RESULTS AND DISCUSSION PART II: PDLSC AS A POTENTIAL
CELL SOURCE FOR HEART VALVE TISSUE ENGINEERING
Cell Phenotype: The ∆Ct values were averaged and normalized with
GAPDH using the ∆∆Ct method (38). Fold changes were calculated as 2-∆Ct and
the gene expression ratio of each of the four groups (negative control,
differentiating media, BioFlux, and differentiating media + BioFlux) indicated as
shown on Figure 14. ANOVA test was performed to compare the four groups
pairwise (Table 2 through 7). Table 8 summarizes the gene expression
comparison among all groups. Table 9 on the other hand shows the percentage
increase of gene expression of all groups compared to group 1. There was an
increased percentage of group 4 over groups 2 and 3 in genes Thy-1, Pecam-1
and Flk-1 and Ve-Cadherin.
Based on results from qRT-PCR on Figure 14, P-values from Tables (2
through 7) as well as gene expression comparison (Table 8) and percentage
increase comparison (Table 9) it was determined that the highest gene presence
for both smooth muscle cells and endothelial cells was produced from RNA
extracted from group 4, i.e., PDLSCs exposed to our differentiating media and
flow in the BioFlux system (1dyne/cm2). There was a significant affect (P < 0.05)
of these two variables for the cells to positively express genes for both smooth
muscle

(beta-1 integrin and Thy 1) and endothelial (Pecam-1, Flk-1, VE32

Cadherin) cell phenotypes compared to all other groups. There were also
significant differences (P < 0.05) in the expression of all genes when comparing
them against each other as seen on Tables 2 through 8. However, these results
also showed a considerable effect in the differentiative capacity of PDLSCs
based on just flow (group 3) or differentiation medium (group 2) as both of these
groups developed gene expression in the qRT-PCR results. The effect of
differentiation medium alone on PDLSCs was significant (P < 0.05) for EC gene
expression over basal medium; however, it was not for SMC gene expression
(Tables 2 through 7). Similarly, the effect of flow alone on PDLSCs compared to
basal medium without flow was significantly different (P < 0.05) for both SMC and
EC phenotypes. Therefore flow alone had a higher effect on the differentiative
capacity of PDLSCs than the differentiative medium. Our control group (group 1)
of cells that were cultured under their regular basal medium did not show
significant expression of either SMC or EC phenotypes.
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Figure 14: Quantitative RT-PCR of PDLSC (n=3). Group 1: Cells cultured in regular basal medium.
Group 2: Cells cultured in differentiating media. Group 3: Cell cultured in basal medium and exposed
to 1 dyne/cm2. Group 4: Cells cultured in differentiating media and exposed to 1 dyne/cm2. Each
column is normalized by GAPDH.

Table 2: P-value for GAPDH gene expression within the four groups.

GAPDH

Sum of
Squares
(SS)

Degrees of
Freedom
(df)

Groups
Error

0.78
0.30

3
8

Total

1.08

11

Mean of
Squares
(MS)

F-Test

0.26
0.04

P-Value
6.97

0.0127

Table 3: P-value for Beta-1-Integrin gene expression within the four groups.

Beta-1Integrin

SS

df

MS

Groups
Error

79.35
4.48

3
8

Total

83.83

11

F-Test
26.45
0.56
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P-Value
47.2

1.97 x10^5

Table 4: P-value for THY-1 gene expression within the four groups.

THY-1

SS

df

MS

Groups
Error

45.84
6.79

3
8

Total

52.63

11

F-Test
15.28
0.85

P-Value

17.99

0.0006

Table 5: P-value for PECAM-1 gene expression within the four groups.

PECAM-1

SS

df

MS

Groups
Error

162.39
1.56

3
8

Total

163.95

11

F-Test
54.13
0.20

P-Value

277.59

2.01x10^8

Table 6: P-value for FLK-1 gene expression within the four groups.

FLK-1

SS

df

MS

Groups
Error

156.67
3.35

3
8

Total

160.02

11

F-Test
52.22
0.42

P-Value

124.58

4.71x10^7

Table 7: P-value for VE-CADHERIN gene expression within the four groups.

VECADHERIN

SS

df

MS

Groups
Error

119.20
11.86

3
8

Total

131.06

11

F-Test
39.73
1.48

P-Value
26.8

0.0002

Table 8: Gene expression comparison among all groups

Groups being compared

Genes significantly different from Group 4 (p<0.05)

Group 1 vs. Group 4

B-1-integrin, Thy 1, Pecam-1, Flk-1, Ve-cadherin

Group 2 vs. Group 4

B-1-integrin, Thy 1, Pecam-1, Flk-1

Group 3 vs. Group 4

Ve-Cadherin
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Table 9: Percentage Increase of Gene Expression per Group Compared to Group 1

BETA-IINTEGRIN
THY-1
PECAM-1
FLK-1
VE-CADHERIN

GROUP 2 VS. GROUP 1
59.43%

GROUP 3 VS. GROUP 1
98.92%

GROUP 4 VS. GROUP 1
98.93%

-251.80%
92.07%
99.25%
99.53%

92.06%
99.72%
97.86%
97.86%

95.15%
99.87%
99.887%
99.51%

Immunohistochemistry: PDLSCs from group 1 (negative control) did not
stain positive for either alpha-sma or vWF (Figure 15 (A and B)). While PDLSCs
from group 2 showed positive staining for both gene markers (Figure 15C, 15D).
In a similar manner, PDLSCs from groups 3 and 4 stained positively for both
smooth muscle (alpha-sma) and endothelial cell markers (vWF) (Figure 16 (A
and B); and Figure (16 and D)). Positive staining was confirmed with positive
controls, i.e. smooth muscle cells and endothelial cells (Figure 17 (A and B)).

36

Figure 15: (A and B) represents staining for alpha-sma for cells from group 1: negative staining (A)
and group 2: positive staining (B), while Figure 9(C and D) represents staining for vWF for cells from
group 1: negative staining (A) and group 2: positive staining (B). DAPI (Blue) marks the nucleus of
the cells, while Texas Red (Red) marks either alpha-sma (A and C) or vWF (B and D). The images
were taken at 20X, on an upright fluorescent microscope.
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Figure 16: (A and C) represents positive staining for alpha-sma for cells from group 3 (A) and group
4 (B), while Figure 10(B and D) represents positive staining for vWF for cells from group 3 (A) and
group 4 (B). Texas Red (Red) marks either alpha-sma (A and C) or vWF (B and D). The images were
taken at 20X, on an inverted fluorescent microscope.

vWF

alpha-sma

Figure 17: (A) represents positive staining to alpha-sma for mooth muscle cells, while (B) represents
positive staining for vWF for endothelial cells. DAPI (Blue) marks the nucleus of the cells, while
Texas Red (Red) marks either alpha-sma (A ) or vWF (B). The images were taken at 20X, on an
upright fluorescent microscope.
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Over the past decade, the potential of BMSCs to provide regenerative
treatment strategies in cardiac disease have been investigated (1,5-9).
Researchers have found that MSCs differentiate in vitro into cardiomyocytes and
smooth muscle cells, however, there has not yet been clear evidence of MSCs
differentiation to endothelial lineages under solely biomechanical environments
(8, 43, 44). Embryonic stem cells (ESCs), on the other hand have been shown to
have a high potency to develop cardiac phenotypes including both SMCs and
ECs (13,14). In our study we utilized PDLSCs because subpopulations of this cell
lineage have shown to express ESCs markers (Oct4, Sox2, Nanog, and Klf4),
therefore exhibiting a higher differential potential than MSCs (12). Owing to their
more primitive state, PDLSCs offer the possibility to differentiate into neurogenic
(ectoderm), as well cardiomyogenic, osteogenic and chondrogenic (mesoderm)
cell lineages suggesting extensive pluripotency capacities. To date, the only
pluripotent stem cells with capacity to differentiate into the three germal layers
(ectoderm, mesoderm and endoderm) are ESCs, however, based on recent
findings by Huang et al (12) PDLSCs may provide similar pluripotency and
perhaps the only cell type that can be derived from adults. In addition, PDLSCs
can easily be culture expanded and are potentially more immune-tolerant
compared to BMSCs, and therefore could be used in an allogenic manner.
These properties make PDLSCs an especially attractive cell source for
cardiovascular tissue engineering therapeutics for use in applications such as
severe congenital heart valve disease and anomalies.
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After examining phenotypic changes in the PDLSCs from all four groups
using immunohistochemistry and RT-PCR we found out that there is a significant
effect of culturing the cells with our differentiating cocktail media containing and
dynamic conditioning by means of flow (1 dyne/cm2). Also, the use of only
cocktail media, or shear stress (1 dyne/cm2) also has an effect in valve like
expression. However, flow has a much more dominant effect in comparison to
biochemical stimulants in differentiating PDLSCs into valve phenotypes.
7. RESULTS AND DISCUSSION PART III: VASCULAR CELL
MIGRATORY ACTIVITY UNDER DYNAMIC STATES COMPARED TO
STATIC CONTROLS BY SPIO-LABELED CELLS
To observe cell behavior in a scaffold environment under static and steady flow
states, we scaled up our studies to 3-D culture, with a focus on cell detection,
visualization and distribution using the PDLSCs.
MR Imaging: SPIO-labeled PDLSCs seeded in the PGA/PLLA scaffold
under rotisserie culture for 1 week and subsequently housed in our u-shaped
bioreactor were successfully labeled under a concentration of 200 μg/ml (Figure
18). The MRI scan parameters for the resulting T2*-weighted images that were
acquired were with 60mm resolution and 11.2ms TE and 100ms TR.
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Figure 18: MRI of PDLSC-seeded scaffolds in situ within the U-shaped bioreactor. The figure shows
axial and sagittal slices from T2*-weighted images. Dark spots within the scaffold region are cells,
which are hypointense due signal attenuation caused by the intracellular SPIO micro-particles.

Histology: We report representative histology for the PDLSCs, which
were fixed and embedded with paraffin at different time points, cut in a
microtome at 10µm in the axial direction, and stained for hematoxilyn and eosin
(H&E) for general morphology (Figure 19). More cells were observed when
cultured under flow conditions; meaning flow allows more cells to remain viable.
Also, changes in morphology under flow states suggest induced differentiation.
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Figure 19: H&E staining for general tissue assessment and organization of PDLSCs 2 weeks of
culturing (A): Cultured under flow conditions. (B): Cultured under static conditions. Magnification is
20x.

Fluorescent Validation for PDLSC seeded scaffold: Sections were also
mounted and stained for DAPI with Vectashield Mounting Media (Invitrogen,
Carlsbad, CA)) and examined under an inverted fluorescent microscope to
further validate the MR image for presence of the red tag contained in the Bangs
particles for further validation of the iron oxide presence inside the cells (Figure
20).
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Figure 20: Immunofluorescence of PDLSC seeded scaffold (A-B) Cultured under static conditions
(C-D) Cultured under flow conditions. Magnification is 20x. DAPI (nucleus), and Red (Bangs
Particles).

DNA Quantification for SMC-EC-seeded Scaffolds: Based on our
seeding density of 2x106 cells/scaffold, and results from Engelmayr et al (1)
suggesting a seeding efficiency of 90% when utilizing PGA/PLLA as the
scaffolding material we assumed that an average of 180,000 cells/scaffold were
retained. Assuming a DNA content of 7.6 pg/cell (45), there was an initial DNA
content of 13.68ug/scaffold. After 3 weeks of incubation the DNA concentration
decreased to 4360 ng/g wet weight (68.1%) in the static group from the initial
DNA concentration. Whereas in the group exposed to dynamic flow it decreased
to 12720 ng/g wet weight (7.0%) as shown in Figure 21. The difference between
the static and flow group is significantly different (p<0.05) meaning less cells died
when they were exposed to flow.
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P < 0.05

Figure 21: DNA content of SMC-EC seeded scaffolds after 3 weeks of incubation. Values presented
are the mean of the measurements for 3 samples. Error bars indicate standard error.

Extra Cellular Matrix Quantification for SMC-EC-seeded Scaffolds:
After the 3 week period, the collagen concentration was 436.8±15.04 ug/g wet
weight in the group exposed to flow compared with 218.9±25.9 ug/g wet weight
in the static group. There was a 99.5% increase in collagen in the group exposed
to flow compared to the static group (p<0.05). On the other hand, the S-GAG
concentration was 351.6±44.5 ug/g wet weight in the group exposed to flow,
compared to 424.38±36.6 ug/g wet weight in the control group. This represents a
17.1% decrease in the GAG production from the scaffolds exposed to flow in
comparison to the static controls (Figure 22), which is not significantly different.
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P < 0.05

N.S

Figure 22: Composition content of SMC-EC seeded scaffolds after 3 weeks of incubation. Values
presented are the mean of the measurements for 3 samples. Error bars indicate standard error.
Insignificant comparisons are designated by ‘‘N.S.’’. The group exposed to flow exhibited a 99.5%
increase in collagen compared to the static group (p <0.05) (n=3) (r=5).

DNA Quantification for PDLSC-seeded Scaffolds: DNA was quantified
in the same way as for the SMC-EC-seeded scaffolds. Similarly, a seeding
density of 2x106 cells/scaffold was utilized, and 90% cell retention was assumed.
Therefore based on the 7.6 pg DNA content/cell (45), there was an average initial
DNA content of 13.68ug/scaffold. 3 weeks post culture of the scaffold, the DNA
concentration decreased to 4130 ng/g (69.8%)wet weight in the static group and
decreased 8830 ng/g wet weight (35.5%) in the group exposed to dynamic flow
as shown on Figure 23. The difference between the static and flow group is
significantly different (p<0.05) meaning less cells died when they were exposed
to flow.
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P < 0.05

Figure 23: DNA content of PDLSC seeded scaffolds after 3 weeks of incubation. Values presented
are the mean of the measurements for 3 samples. Error bars indicate standard error. (n=3) (r=5).

Extra Cellular Matrix Quantification for PDLSC-seeded Scaffolds:
After the 3 week period, for the PDLSC-seeded scaffolds the collagen
concentration was 400.2±13.2 ug/g wet weight in the group exposed to flow
compared with 207.8±10.2 ug/g wet weight in the static group. There was a
93.3% increase in collagen group exposed to flow compared to the static group
(p<0.05). Furthermore, the S-GAG concentration was 296.0±15.6 ug/g wet
weight in the group exposed to flow, compared to 307.5±15.6 ug/g wet weight in
the control group. This represents a 3.7% decrease in the GAG production from
the scaffolds exposed to flow in comparison to the static controls, which is not
significantly different (Figure 24).
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Figure 24: Composition content of PDLSC seeded scaffolds after 3 weeks of incubation. Values
presented are the mean of the measurements for 3 samples. Error bars indicate standard error.
Insignificant comparisons are designated by ‘‘N.S.’’. The group exposed to flow exhibited a 93.3%
increase in collagen compared to the static group (p <0.05). (n=3)(r=5)

Mechanical conditioning is believed to stimulate tissue formation in
engineered tissues. It has been shown by researchers (9,18-21) that mechanical
properties of engineered heart valves can be improved through bioreactor-based
mechanical stimulation. The u-shaped bioreactor utilized in our study has the
potential to provide physiological hemodynamic conditions during in vitro tissue
development while keeping laminar conditions as shown by precise steady state
states which is an essential aspect for tissue formation. The effects of fluid shear
stress on tissue formation can then be evaluated by bulk protein, differentiation
capacity, mechanical properties and cell signaling events.
We were able to successfully image a 3D construct with ferumoxidelabeled PDLSCs under MRI, and further validate the presence of iron oxide
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indirectly via fluorescent microscopy. At the same time we showed the general
distribution of the PDLSCs that were seeded onto a 50:50 PLLA/PGA blend of
biodegradable scaffolds through H&E staining. Thus, cell visualization on 3-D
scaffolds specimens could be successfully carried out in situ in the U-shaped
bioreactor, intermittently, during the steady flow-conditioning period.

These

findings demonstrate the ability to successfully conduct cell tracking studies on
scaffolds that are undergoing a mechanical conditioning process in a longitudinal
fashion, using MRI.
An intrinsic goal of TEPV efforts is to recapitulate native valve extra
cellular matrix protein concentrations, namely, collagen, GAG and elastin. In our
study we found that mechanical stimulation by means of a physiological relevant
flow (750 mL/min) augmented the collagen production in both EC-SMC and
PDLSC seeded scaffolds after 3 weeks of culture (1 week static + 2 week
dynamic). SMC-EC seeded scaffolds were subjected to dynamic flow exhibiting
increased collagen mass production levels compared to our static controls.
Similarly, PDLSC seeded scaffolds exposed to dynamic flow also displayed
higher collagen formation than non-flow cultured scaffolds. This represents a
similar behavior in tissue formation by both SMC-EC and PDLSC seeded
scaffolds. Also, consistent with other researchers (1,5), we found a reduction in
the GAG concentration when applying dynamic flow to the cell-seeded scaffolds.
Flanagan et al and Balguid et al (46,47) performed some studies on GAG
production, finding that the integration of a GAG constituent to the scaffold
causes enhanced extracellular matrix production.
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The accelerated collagen

formation rates in the flow-groups may limit the cells ability to synthesize large
concentrations of GAGs simultaneously.

GAG concentrations in the TEPV

constructs reflective of native valves may be reached by exogenous
supplementation; alternatively, some level of initial static tissue culture may be
necessary before initiating the dynamic conditioning protocols. In addition we did
not examine elastin levels in our experiments. Thus, further investigations are
needed in order to further optimize the tissue engineering protocol.
DNA content of both SMC-EC and PDLSC scaffolds was decreased after
3 weeks of culture on both static and dynamic groups. This would mean that less
cells are retained in the tissue over time, however the ability of the cells to
secrete more collagen increases with physiological flow conditioning.
For future studies, we would like to incorporate the flex and stretch
features of the u shaped bioreactor, and see how cyclic flexure affects tissue
formation over a 3 week period.
8. CONCLUSION
In summary, we were able to detect spatial position of cells noninvasively
using MRI. The cells (SMCs, ECs and PDLSCs) were efficiently labeled with
SPIO microparticles at an optimum concentration of 200µg/mL in combination
with of transfection agents, protamine sulfate at a concentration of 4.5µg/mL for
vascular cells and 12µg/mL for stem cells. The iron oxide presence inside the
cells was confirmed

by fluorescence microscopy (red tag). We expect that the
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cellular MRI techniques performed for the cell populations in this study will guide
protocol optimization during in vitro to in vivo translation of TEPV constructs.
On a separate note, we found that PDLSCs subjected to differentiating
media, and a shear stress of 1 dyne/cm2 induces differentiation to SMC and EC
phenotypes. PDLSCs have the potential to become a single cell source feasible
for the creation of tissue engineering pulmonary valves as they have the ability to
support valve cell phenotypes (e.g. SMC s and ECs). They can be easily culture
expanded and possess sufficient plasticity to remodel into valve tissue thus
making them an appealing cell source for heart valve tissue engineering.
We studied the effects of mechanical stimulation by means of steady flow,
by the use of our u-shaped bioreactor, in which we placed seeded SMC-EC and
PDLSC seeded scaffolds and effectively obtained more robust collagen matrix
production. Therefore, the study shows that both native cells (SMC-EC) and our
viable cell source (PDLSC) both augmented levels of collagen production when
stimulated by physiological levels of flow. Cellular scaffolds were also
successfully visualized in situ in the u-shaped bioreactor and successfully
validated by means of histology and fluorescence microscopy.
Significance: This project has an overall impact in the field of TEPVs.
Specifically, it leads to a better understanding of the cell distribution of vascular
cells and stem cells under static as well as steady flow states.

Fluid shear

stresses are one of the major physical stimulatory components of native heart
valve and thus from a biomimetic viewpoint is relevant to heart valve tissue
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engineering studies. Also, we introduced PDLSC into the heart valve tissue
engineering field; they were presented as a potential allogenic cell source for
creating heart valve constructs by demonstrating concomitant differentiation into
EC and SMC phenotypes. In particular, more complete EC differentiation was
observed under combined biochemical and flow states. VE-CADHERIN was
uniquely expressed under these conditions, which is indispensable for proper
vascular development.
Future Work: We hope that future in vitro studies will include longitudinal
MR imaging of SPIO-labeled cells (SMC-EC and PDLSC) seeded on PGA/PLLA
to be able to understand further the migration of cells when exposed to flow
conditions in the u-shaped bioreactor. These studies can be then compared to
the findings from this project related to tissue formation, differentiative capacity,
plus histological and fluorescent validation of the iron oxide presence inside the
cells. In addition, other stress states such as pulsatile flow, cyclic flexure and
dynamic tensile stresses individually or in a coupled manner, need to be further
investigated. Nonetheless this work has taken the first steps in delineating the
role of a fluid-induced stress state on cells relevant to engineered heart valve
tissue engineering and forms the basis for further work that will examine the
mechano-biology of evolving heart valve tissues.
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